| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 3, 2024Virtual Press Office and PR Newswire: General Trade show news
CAHtalyst™ Pediatric Study Baseline Characteristics Data Highlight Need for Novel Treatments in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH) CAHtalog™ Registry Data of...
-
May 3, 2024Virtual Press Office and PR Newswire: General Trade show news
Study highlights opportunity for treatment intensification in this population since approximately 50% of patients with high-risk localized prostate cancer (HRLPC) experience disease recurrence...
-
May 3, 2024Virtual Press Office and PR Newswire: General Trade show news
New data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98% achieving a CR within 12 weeks TAR-200 provides durable CRs in patients with Bacillus...
-
May 3, 2024Virtual Press Office and PR Newswire: General Trade show news
Findings highlight the novel mechanism of action and potential for therapeutic activity in highly inflammatory autoimmune disease SEATTLE, May 3, 2024 /PRNewswire/ -- Mozart Therapeutics, the...
-
May 3, 2024RSAC Media Center
Organizations using end-of-life console servers must reduce their vulnerability exposure and secure their infrastructure comprehensively by using ZPE's console servers, installation services and...
